Zai Lab shows strong growth in oncology/autoimmune drugs; reduced losses and efficient operations evident in Q3 results. Healthy financial status with a strong current ratio of 7.68; reduced R&D ...

Quick Read Rocket Lab (RKLB) stock rose 174% in 2025 and completed a record 21 Electron missions. Rocket Lab’s Neutron rocket ...

Both companies are attacking massive addressable markets with differentiated products, but one has a clearer path to sustained hypergrowth. Wall Street's obsession with artificial intelligence (AI) ...

Rocket Lab (RKLB) has quietly turned into one of the market's stronger space names this year, with the stock up around 55% over the past month and 165% over the past year. See our latest analysis for ...

Investors in the commercial space industry are showing increased interest in Rocket Lab USA, Inc. (NASDAQ: RKLB). Due to its focus on innovation and market demands, the company has grown from a small ...

Rocket Lab has delivered exceptional performance, with shares up nearly 175% year to date, yet remains early in a ...

Rocket Lab (RKLB) valuation vs growth: 48x revenue, mega satellite deal, Neutron delay, margin outlook and key chart levels.

As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and ...

As we approach a new year, it is the perfect time to add some new money to some of the most promising growth stocks on the market. While the broader S&P 500 index remains within a couple of percentage ...

A new podcast from LOCALiQ and the USA TODAY NETWORK was released today targeted towards business owners and leaders. The Growth Lab podcast explores topics in the areas of business and leadership, ...

Wall Street loves a good David versus Goliath story. But what happens when two Davids are battling entirely different giants? Rocket Lab reported $123 million in first-quarter 2025 revenue, reflecting ...